Position in NVS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,570,020
+$1,082,901 QoQ
Shares Held
10,018
+214.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#491
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Occidental Asset Management, LLC holds $27,487,329 across 9 Drug Manufacturers - General names. NVS ranks #7 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
56,777 | $7,295,844 | |
| 2 | AMGN |
Amgen Inc
|
17,469 | $6,325,874 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
34,701 | $4,384,124 | |
| 4 | ABBV |
AbbVie Inc.
|
10,577 | $2,661,596 | |
| 5 | LLY |
ELI LILLY & Co
|
2,219 | $2,661,535 | |
| 6 | JNJ |
Johnson & Johnson
|
7,491 | $1,902,489 | |
| 7 | NVS |
Novartis AG
This page
|
10,018 | $1,570,020 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
7,807 | $449,839 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,570,020 | 10,018 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $487,119 | 3,189 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $412,507 | 2,992 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $354,327 | 2,763 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $330,841 | 2,734 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $308,576 | 2,768 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $261,763 | 2,690 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $309,403 | 2,690 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $265,085 | 2,490 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $241,825 | 2,500 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $251,415 | 2,490 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $369,038 | 3,623 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $373,669 | 3,703 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $361,376 | 3,928 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $358,797 | 3,955 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $236,011 | 3,105 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $262,465 | 3,105 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $307,212 | 3,501 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $305,620 | 3,494 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $285,003 | 3,485 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $317,971 | 3,485 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $297,897 | 3,485 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $332,771 | 3,524 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $310,882 | 3,575 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $319,053 | 3,653 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $304,735 | 3,696 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||